Prague Med. Rep. 2020, 121, 172-180

https://doi.org/10.14712/23362936.2020.16

Serum Galectin-3 Levels Are Unlikely to Be a Useful Predictive Marker for Early-onset Preeclampsia Development

Asparuh Nikolov1, Nikola Popovski2, Alexander Blazhev3

1Scientific Division of Medicine, Institute for Scientific Research, Medical University of Pleven, Pleven, Bulgaria
2Clinic of Obstetrics and Gynecology, University Hospital Pleven, Medical University of Pleven, Pleven, Bulgaria
3Division of Biology, Medical University of Pleven, Pleven, Bulgaria

Received May 6, 2020
Accepted September 14, 2020

References

1. Alves, C. M., Silva, D. A., Azzolini, A. E., Marzocchi-Machado, C. M., Carvalho, J. V., Pajuaba, A. C., Lucisano-Valim, Y. M., Chammas, R., Liu, F. T., Roque-Barreira, M. C., Mineo, J. R. (2010) Galectin-3 plays a modulatory role in the lifespan and activation of murine neutrophils during early Toxoplasma gondii infection. Immunobiology 215, 475–485. <https://doi.org/10.1016/j.imbio.2009.08.001>
2. Blois, S., Barrientos, G. (2014) Galectin signature in normal pregnancy and preeclampsia. J. Reprod. Immunol. 102, 127–134. <https://doi.org/10.1016/j.jri.2013.05.005>
3. Brinchmann, M. F., Patel, D. M., Iversen, M. H. (2018) The role of galectins as modulators of metabolism and inflammation. Mediators Inflamm. 2018, 9186940. <https://doi.org/10.1155/2018/9186940>
4. Ferguson, K. K., Meeker, J. D., McElrath, T. F., Mukherjee, B., Cantonwine, D. E. (2017) Repeated measures of inflammation and oxidative stress biomarkers in preeclamptic and normotensive pregnancies. Am. J. Obstet. Gynecol. 216(5), 5271–5279. <https://doi.org/10.1016/j.ajog.2016.12.174>
5. Gallo, M., Wright, D., Casanova, C., Campanero, M., Nicolaides, K. (2016) Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19–24 weeks’ gestation. Am. J. Obstet. Gynecol. 214(5), 6191–6197. <https://doi.org/10.1016/j.ajog.2015.11.016>
6. Hirashima, C., Ohkuchi, A., Nagayama, S., Suzuki, H., Takahashi, K., Ogoyama, M., Takahashi, H., Shirasuna, K., Matsubara, S. (2018) Galectin-1 as a novel risk factor for both gestational hypertension and preeclampsia, specifially its expression at a low level in the second trimester and a high level after onset. Hypertens. Res. 41(1), 45–52. <https://doi.org/10.1038/hr.2017.85>
7. Iglesias, M. M., Rabinovich, G. A., Ambrosio, A. L., Castagna, L. F., Sotomayor, C. E., Wolfenstein-Todel, C. (1998) Purification of galectin-3 from ovine placenta: Developmentally regulated expression and immunological relevance. Glycobiology 8, 59–65. <https://doi.org/10.1093/glycob/8.1.59>
8. Kalousová, M., Muravská, A., Zima, T. (2014) Pregnancy-associated plasma protein A (PAPP-A) and preeclampsia. Adv. Clin. Chem. 63, 169–209. <https://doi.org/10.1016/B978-0-12-800094-6.00005-4>
9. Karumanchi, S. A., Granger, J. P. (2016) Preeclampsia and pregnancy-related hypertensive disorders. Hypertension 67, 238–242. <https://doi.org/10.1161/HYPERTENSIONAHA.115.05024>
10. Kaya, B., Turhan, U., Sezer, S., Kaya, S., Dağ, İ. (2020) Maternal serum galectin-1 and galectin-3 levels in pregnancies complicated with preterm prelabor rupture of membranes. J. Matern. Fetal Neonatal. Med. 33(5), 861–868. <https://doi.org/10.1080/14767058.2019.1637409>
11. Ochieng, J., Green, B., Evans, S., James, O., Warfield, P. (1998) Modulation of the biological functions of galectin-3 by matrix metalloproteinases. Biochim. Biophys. Acta 1379, 97–106. <https://doi.org/10.1016/S0304-4165(97)00086-X>
12. Patil, M., Panchanadikar, T. M., Wagh, G. (2014) Variation of Papp-A level in the first trimester of pregnancy and its clinical outcome. J. Obstet. Gynaecol. India 64(2), 116–119. <https://doi.org/10.1007/s13224-013-0481-4>
13. Phillips, B., Knisley, K., Weitlauf, K. D., Dorsett, J., Lee, V., Weitlauf, H. (1996) Differential expression of two beta-galactoside-binding lectins in the reproductive tracts of pregnant mice. Biol. Reprod. 55, 548–558. <https://doi.org/10.1095/biolreprod55.3.548>
14. Rolnik, D. L., Wright, D., Poon, L. C., O’Gorman, N., Syngelaki, A. (2017) Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N. Engl. J. Med. 377(7), 613–622. <https://doi.org/10.1056/NEJMoa1704559>
15. Sung, K. U., Jeong, A. R., Kyung, J. E., Hyeok, K. E. (2017) Maternal serum placental growth factor and pregnancy-associated plasma protein A measured in the first trimester as parameters of subsequent pre-eclampsia and small-for-gestational-age infants: a prospective observational study. Obstet. Gynecol. Sci. 60(2), 154–162. <https://doi.org/10.5468/ogs.2017.60.2.154>
16. Taha, A. S., Zahraei, Z., Al-Hakeim, H. (2020) Serum apelin and galactin-3 in preeclampsia in Iraq. Hypertens. Pregnancy 2020, 1–8. <https://doi.org/10.1080/10641955.2020.1777300>
17. Tsiakkas, A., Duvdevani, N., Wright, A., Wright, D., Nicolaides, K. H. (2015) Serum placental growth factor in the three trimesters of pregnancy: Effects of maternal characteristics and medical history. Ultrasound Obstet. Gynecol. 45, 591–598. <https://doi.org/10.1002/uog.14811>
18. Villar, J., Carroli, G., Wojdyla, D., Abalos, E., Giordano, D. (2006) Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions? Am. J. Obstet. Gynecol. 194(4), 921–931. <https://doi.org/10.1016/j.ajog.2005.10.813>
19. Yang, H., Lei, C., Zhang, W. (2012) Expression of galectin-3 in mouse endometrium and its effect during embryo implantation. Reprod. Biomed. Online 24, 116–122. <https://doi.org/10.1016/j.rbmo.2011.09.003>
front cover

ISSN 1214-6994 (Print) ISSN 2336-2936 (Online)

Archive